Subtype
Breast Carcinoma
CI-CAN-00000594Explore in graph →
873 active trials12 approved drugs113 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000594Explore in graph →
Clinical trials
2,394 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (365)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00684983 | Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer | completed | Phase 2 | 64 | National Cancer Institute (NCI)NIH | 1 | Mar 24, 2020 | clinicaltrials |
| NCT02789332 | Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency(GeparOla) | completed | Phase 2 | 107 | GBG Forschungs GmbH |
| 1 |
| Mar 17, 2020 |
| clinicaltrials |
| NCT04290585 | Technology and Health Communication in Improving Health Outcomes in Patients Scheduled for Mammography | completed | N/A | 160 | Fox Chase Cancer CenterOTHER | 1 | Mar 2, 2020 | clinicaltrials |
| NCT00376688 | Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 2 | 31 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2020 | clinicaltrials |
| NCT02766881 | Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS(DUCHESS) | completed | — | 281 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Feb 19, 2020 | clinicaltrials |
| NCT00343109 | Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer | completed | Phase 2 | 38 | University of WashingtonOTHER | 1 | Feb 12, 2020 | clinicaltrials |
| NCT01355393 | Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer | completed | Phase 1 / Phase 2 | 50 | University of WashingtonOTHER | 1 | Feb 10, 2020 | clinicaltrials |
| NCT02961790 | Oxybutynin Chloride in Managing Hot Flashes | completed | Phase 3 | 150 | Academic and Community Cancer Research UnitedOTHER | 1 | Jan 18, 2020 | clinicaltrials |
| NCT03348696 | Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer Patients(REaCT-TAPS) | completed | Phase 4 | 124 | Ottawa Hospital Research InstituteOTHER | 1 | Jan 9, 2020 | clinicaltrials |
| NCT01720602 | Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy | completed | N/A | 15 | University of WashingtonOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT04209010 | Immediate Breast Reconstruction With Acellular Dermal Matrix | completed | — | 44 | Aarhus University HospitalOTHER | 0 | Jan 3, 2020 | clinicaltrials |
| NCT03964896 | Nurse-Driven Telephone Intervention in Improving Side Effects in Cancer Patients Undergoing Chemotherapy | completed | N/A | 90 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 24, 2019 | clinicaltrials |
| NCT00390455 | Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive | completed | Phase 3 | 295 | National Cancer Institute (NCI)NIH | 1 | Dec 20, 2019 | clinicaltrials |
| NCT00880503 | Collection of Tissue Samples for Study of Multidrug Resistance | completed | — | 325 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2019 | clinicaltrials |
| NCT01894451 | Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy | completed | Early Phase 1 | 2 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 12, 2019 | clinicaltrials |
| NCT01783756 | Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis | completed | Phase 1 / Phase 2 | 9 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Nov 12, 2019 | clinicaltrials |
| NCT01641068 | Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms | completed | N/A | 20 | University of WashingtonOTHER | 1 | Nov 8, 2019 | clinicaltrials |
| NCT01084057 | Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 | 56 | City of Hope Medical CenterOTHER | 1 | Nov 5, 2019 | clinicaltrials |
| NCT01753908 | Broccoli Sprout Extract in Treating Patients With Breast Cancer | completed | Early Phase 1 | 30 | Roswell Park Cancer InstituteOTHER | 1 | Oct 31, 2019 | clinicaltrials |
| NCT01869764 | Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer | completed | Phase 2 | 57 | Wake Forest University Health SciencesOTHER | 1 | Oct 30, 2019 | clinicaltrials |
| NCT02545023 | Supportive Care Questionnaires in Gathering Data on Unmet Needs and Health-Related Quality of Life in Latina Breast Cancer Survivors After Surgery, Chemotherapy, or Radiation Therapy | completed | — | 100 | University of Southern CaliforniaOTHER | 1 | Oct 23, 2019 | clinicaltrials |
| NCT01806675 | 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy | completed | Phase 1 / Phase 2 | 25 | Sanjiv Sam GambhirOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT01856543 | Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation | completed | Phase 3 | 143 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT02640053 | Topical Cryotherapy in Reducing Pain in Patients With Chemotherapy Induced Peripheral Neuropathy or Paclitaxel Induced Acute Pain Syndrome | completed | N/A | 46 | Academic and Community Cancer Research UnitedOTHER | 1 | Sep 30, 2019 | clinicaltrials |
| NCT01964924 | Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Sep 20, 2019 | clinicaltrials |
| NCT01815476 | The Prone Breast Radiation Therapy Trial | completed | N/A | 378 | Toronto Sunnybrook Regional Cancer CentreOTHER | 1 | Sep 11, 2019 | clinicaltrials |
| NCT01153672 | Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy | completed | N/A | 8 | University of WashingtonOTHER | 1 | Sep 6, 2019 | clinicaltrials |
| NCT02248662 | Impact of Radiation Therapy on Breast Conservation in DCIS | completed | — | 3,436 | Dana-Farber Cancer InstituteOTHER | 1 | Sep 6, 2019 | clinicaltrials |
| NCT02816164 | A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia(REaCT-G2) | completed | Phase 4 | 324 | Ottawa Hospital Research InstituteOTHER | 1 | Sep 6, 2019 | clinicaltrials |
| NCT03247478 | Computed Tomography (CT) Reconstruction for Axillary Lymph Node Structure(CTREP) | completed | — | 160 | Peking UniversityOTHER | 1 | Sep 6, 2019 | clinicaltrials |
| NCT02307240 | Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors | completed | Phase 1 | 43 | Curis, Inc.INDUSTRY | 1 | Sep 3, 2019 | clinicaltrials |
| NCT01975363 | Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer | completed | N/A | 29 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Aug 30, 2019 | clinicaltrials |
| NCT03609671 | Emotions Immunology and Breast Cancer | completed | N/A | 17 | Luz A. Venta, MDOTHER | 1 | Aug 28, 2019 | clinicaltrials |
| NCT00513695 | Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer | completed | Phase 2 | 68 | University of WashingtonOTHER | 1 | Aug 7, 2019 | clinicaltrials |
| NCT02216136 | Tumor: Breast Ratio Study(T:B) | completed | — | 162 | Washington University School of MedicineOTHER | 1 | Aug 2, 2019 | clinicaltrials |
| NCT02806817 | ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism | completed | Early Phase 1 | 40 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Jul 23, 2019 | clinicaltrials |
| NCT02611544 | Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors | completed | N/A | 91 | Indiana UniversityOTHER | 1 | Jun 26, 2019 | clinicaltrials |
| NCT02370277 | Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer | completed | — | 36 | University of Southern CaliforniaOTHER | 1 | Jun 18, 2019 | clinicaltrials |
| NCT02646319 | Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations | completed | Early Phase 1 | 2 | Mayo ClinicOTHER | 1 | Jun 6, 2019 | clinicaltrials |
| NCT01017185 | Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions | completed | Phase 1 | 28 | Takara Bio Inc.INDUSTRY | 1 | May 23, 2019 | clinicaltrials |
| NCT01434303 | Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab Only | completed | Phase 1 | 37 | National Cancer Institute (NCI)NIH | 1 | May 20, 2019 | clinicaltrials |
| NCT02587663 | Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI | completed | N/A | 300 | University of Southern CaliforniaOTHER | 1 | May 16, 2019 | clinicaltrials |
| NCT02908178 | Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ | completed | — | 28,291 | Yale UniversityOTHER | 1 | May 15, 2019 | clinicaltrials |
| NCT03886389 | Breast Cancer Diet Intervention Study(BCDIS) | completed | N/A | 80 | Helse Stavanger HFOTHER_GOV | 0 | May 13, 2019 | clinicaltrials |
| NCT02565758 | ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors | completed | Phase 1 | 85 | AbbVieINDUSTRY | 3 | Apr 5, 2019 | clinicaltrials |
| NCT00886535 | Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity | completed | — | 41 | Milton S. Hershey Medical CenterOTHER | 1 | Mar 14, 2019 | clinicaltrials |
| NCT01881230 | Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)(tnAcity) | completed | Phase 2 / Phase 3 | 191 | CelgeneINDUSTRY | 12 | Feb 21, 2019 | clinicaltrials |
| NCT03430765 | Preventing Persistent Pain and Reducing Depressive and Anxious Symptoms Following Mastectomy and Lumpectomy | completed | N/A | 62 | Katherine HadlandsmythOTHER | 1 | Feb 11, 2019 | clinicaltrials |
| NCT02557776 | Written Genetic Counseling and Mutation Analysis of BRCA1 and BRCA2 to Patients With Breast Cancer(BRCAsearch) | completed | N/A | 542 | Lund UniversityOTHER | 1 | Feb 6, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Mar 24, 2020source: clinicaltrials